StockWatch
·
 Medicinal Chemicals and Botanical Products
Corporate ActionJun 24, 2026, 04:43 PM

Upexi Issues $19.5M Equity in Private Placement to Reduce Debt

AI Summary

Upexi, Inc. announced a private placement offering totaling approximately $19.5 million with an existing institutional accredited investor. The company issued 5,250,000 shares of common stock and pre-funded warrants for up to 6,992,300 shares. The aggregate purchase price of $19,542,634.54 was paid by retiring an equivalent amount of an outstanding secured convertible note, reducing its principal balance to $16,419,340.46.

Key Highlights

  • Upexi, Inc. entered into a Securities Purchase Agreement for a private placement offering.
  • The company issued 5,250,000 shares of common stock at $1.59652 per share.
  • Pre-funded warrants to purchase up to 6,992,300 shares were issued at $1.59631 per warrant.
  • The aggregate purchase price of the offering was $19,542,634.54.
  • The purchase price was paid by retiring $19,542,634.54 of an outstanding $35,961,975 secured convertible note.
  • The outstanding principal balance of the note was reduced to $16,419,340.46.
  • The securities were issued in reliance on Section 4(a)(2) and Rule 506(b) of the Securities Act.
  • Upexi agreed to file a registration statement for the resale of the shares and warrant shares within 30 days.